Adult disease manifestations disease course outcome patients Clinical laboratory manifestations disease course outcome HLA associations inception cohort subjects adult disease ASD Canadian universities Twenty-eight patients female median age disease onset years general clinical features patients identical series frequencies sore throat weight loss lymphadenopathy pleuritis pneumonitis abdominal pain patients recent literature review Liver involvement hepatomegaly abnormal liver function tests LFTs common responsible deaths disease series Severe liver failure conjunction aspirin NSAID therapy aspirin NSAIDs close monitoring LFTs patients ASD disease course Laboratory manifestations similar Leukocytosis equal present patients normochromic normocytic anemia hemoglobin equal g/dl elevated ESR mean follow-up patients months range patients self-limited disease course intermittent course chronic disease course patients deaths disease patients recurrence ASD flares duration milder severity initial episode factor disease exacerbation patients patients chronic disease course ARA Functional Class patients ARA Functional Class II III Patients disease scores controls Pain Physical Disability subscales Arthritis Impact Measurement Scales health status questionnaire Joint radiographs follow-up evaluation typical carpometacarpal intercarpal involvement patients series ASD Three significant predictors unfavorable outcome chronic disease course time clinical remission ABSTRACT TRUNCATED AT WORDS 